Neurologic paraneoplastic syndromes

Neurologic paraneoplastic syndromes of the nervous system
are rare, affecting but 1% of cancer patients. 68 these
syndromes will be caused by a systemic autoimmune reaction
to an “onconeural” antigen shared by each the cancer and therefore the
nervous system. 69 specific autoantibodies are identified
in a few patients with paraneoplastic syndromes of the nervous
system, and therefore these will be related to specific tumors.
treatment of neurologic paraneoplastic syndromes consists of
( a ) treatment of the underlying cancer, that has been shown
to diminish the neurologic impairment in a few cases, 70 and
( b ) suppression of the antibody with steroids, cyclophosphamide,
plasma exchange, and that intravenous immune globulin
( ivig ). such immunosuppression might also cause significant
clinical improvement. 71
lambert-eaton myasthenic syndrome ( lems ) will affect
up to 3% of patients with sclc. 72 lems provides robust support
for the autoimmune basis for neurologic paraneoplastic
syndromes. patients develop immunoglobulin g ( igg ) antibodies
against voltage-gated calcium channels ( vgcc ) within the
presynaptic neurons. decreased calcium entry ends up in decreased
acetylcholine release, leading to a pure motor neuropathy characterized
by muscular weakness. patients present with muscle
weakness preferentially affecting the lower limbs and proximal
muscles. commonly associated could be autonomic dysfunction such
as dry mouth, impotence, constipation, and blurred vision. on
physical examination, deep tendon reflexes in lower extremities
are diminished or absent, and patients have increased strength
once repeated contraction of the concerned muscles, differentiating
lems from typical myasthenia. treatment of the underlying
tumor sometimes results in improvement of lems, and plasma
exchange or ivig might also improve the clinical symptoms. 73
one case-control report urged that these patients affected by
lems may very well have a stronger survival outcome than sclc
patients who don't seem to be affected. 74 the authors hypothesized that
these patients with lems might have a slower rate of tumor
growth partly connected to tumor macrophage infiltration.
paraneoplastic cerebellar degeneration ( pcd ) might have
an indolent or a a lot of sudden onset, typically evolves rapidly,
and might cause ataxia, dysarthria, and dysphagia. symptoms
might be purely cerebellar, or they will additionally be related to
different neurologic manifestations. the disease course for this
impact might be freelance of that of the underlying tumor.
this syndrome has been shown to result from autoantibodies
against the purkinje cells of the cerebellum. 75 in half the
patients of pcd related to sclc, circulating anti-hu
antibodies are found. 76 limbic encephalitis could be a paraneoplastic
impact consisting of memory failure, seizures, and agitation. 77
most of those patients even have detectable anti-hu antibodies
in each the serum and cerebrospinal fluid.
peripheral neuropathies in sclc patients might indicate a
paraneoplastic syndrome. four varieties of paraneoplastic peripheral
neuropathies will occur : pure motor, pure sensory, sensorimotor,
and autonomic. 75 sclc is most strongly associated
with peripheral sensory neuropathy, a rapidly developing severe
disorder in that patients lose sensory modalities during all four
extremities. symptoms sometimes begin proximally and progress
distally. neurologic symptoms sometimes precede the diagnosis of
cancer, and anti-hu antibodies are typically present in high titers. 78
autonomic neuropathy will additionally develop in patients with the
anti-hu antibody. these patients will have the entire autonomic
nervous system affected or might present with isolated dysfunction,
involving the sympathetic or the parasympathetic nervous
system. these patients might develop gastroparesis and that intestinal
pseudo-obstruction ensuing from dysfunction of autonomic
innervation to the gastrointestinal tract similarly.
sclc will be related to myotonia. in neuromyotonia,
spontaneous and continuous muscle fiber activity causes
stiffness and cramping. the muscle activity continues during
sleep, general anesthesia, and peripheral nerve block, other then can
be inhibited by blocking the neuromuscular junction. this
condition is differentiated from the stiff-man syndrome in
that muscle activity goes into quiescence throughout sleep and
general anesthesia. 79 in stiff-man syndrome, the axial lower extremity
muscles are affected most, inflicting such severe spasms
that bone deformities and fractures are reported.
cancer-associated retinopathy ( car ) could be a rare complication
of sclc. patients present with night blindness, photosensitivity,
and that impaired color vision. symptoms typically develop
prior to the detection of cancer, and therefore the disease sometimes progresses
to painless visual loss. visual field testing reveals peripheral
and ring scotomata and loss of visual acuity. the
electroretinogram could be abnormal and establishes the diagnosis.
this paraneoplastic phenomenon is thought to be caused by
autoimmune destruction of photoreceptors with preservation
of the remainder of the optic pathway. steroids, plasmapheresis, or
intravenous igg ( ivigg ) will scale back antibody titer and stabilize
vision in a few cases, other then progressive total loss of vision
is a lot of the rule. eighty paraneoplastic optic neuropathies will also
occur in sclc. 81 these are characterised by visual loss, similarly
as different neurologic changes, and might respond to immunosuppressive
therapy.